Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Clinical trial NCT05915013 · RECRUITING

Trial details

NCT number: NCT05915013
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major Post Traumatic Stress Disorder

Start date: 2023-09-07
Primary completion: 2032-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.